Evidence map›Paper›PMID 27671114›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2016

Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR-Responsive Drug Release, and Synergistic Therapy.

Hui Wang, Kui Wang, Bowei Tian, Richard Revia, Qingxin Mu, Mike Jeon, Fei-Chien Chang, Miqin Zhang

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Multifunctional Magnetic Resonance Imaging Probes.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Theranostic Diagnostics.Results and problems in cell differentiation · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Iron oxide-carbon core-shell nanoparticles for dual-modal imaging-guided photothermal therapy.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hui WangDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Kui WangDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Bowei TianDepartment of Applied Mathematics, University of Washington, Seattle, WA, 98195, USA.
Richard ReviaDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Qingxin MuDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Mike JeonDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Fei-Chien ChangDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
Miqin ZhangDepartment of Materials Science and Engineering, University of Washington, Seattle, WA, 98195, USA.
University of Washington · USUniversity of Washington Applied Physics Laboratory · US

Funding

Multifunctional nanoparticles to improve treatment of human glioblastomaR01CA161953 · NCI · UNIVERSITY OF WASHINGTON · PI ZHANG, MIQIN · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA161953
6 · The paper itself

Abstract

Applications of hydrophobic drug-based nanocarriers (NCs) remain largely limited because of their low loading capacity. Here, development of a multifunctional hybrid NC made of a magnetic Fe3O4 core and a mesoporous silica shell embedded with carbon dots (CDs) and paclitaxel (PTX), and covered by another layer of silica is reported. The NC is prepared via a one-pot process under mild condition. The PTX loading method introduced in this study simplifies drug loading process and demonstrates a high loading capacity due to mesoporous silica dual-shell structure, supramolecular π-stacking between conjugated rings of PTX molecules, and aromatic rings of the CDs in the hybrid NC. The CDs serve as both confocal and two-photon fluorescence imaging probes, while the Fe3O4 core serves as a magnetic resonance imaging contrast agent. Significantly, NC releases PTX in response to near infrared irradiation as a result of local heating of the embedded CDs and the heating of CDs also provides an additional therapeutic effect by thermally killing cancer cells in tumor in addition to the chemotherapeutic effect of released PTX. Both in vitro and in vivo results show that NC demonstrates high therapeutic efficacy through a synergistic effect from the combined chemo-photothermal treatments.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorDoxorubicinDrug CarriersDrug Delivery SystemsDrug LiberationHumansHydrophobic and Hydrophilic InteractionsMiceMultimodal ImagingAntineoplastic AgentsDoxorubicinDrug Carriershydrophobic drugsmesoporous silicamultifunctional imagingpreloadingsynergistic effects

Identifiers

PMID27671114
PMCPMC5253133
OpenAlexW2524258262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.